Who are aTyr Pharma, Inc.'s main suppliers?

aTyr Pharma, Inc. (ATYR) key suppliers include: CDMOS, CROS, INVESTIGATIVE-SITES, LABORATORY-SUPPLIES. View the full supplier network at chainsifter.com/chain/ATYR.

Who are aTyr Pharma, Inc.'s major customers?

aTyr Pharma, Inc. (ATYR) key customers include: Myriad Genetics, Inc., Myriad Genetics, Inc.. View the full customer network at chainsifter.com/chain/ATYR.

What sector is aTyr Pharma, Inc. in?

aTyr Pharma, Inc. (ATYR) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

aTyr Pharma, Inc. Suppliers, Customers & Supply Chain (ATYR)

4Suppliers

2Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

aTyr Pharma, Inc. (ATYR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships

2Distinct source URLs

7High confidence

0.834Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

aTyr Pharma, Inc. Suppliers

Ticker	Name	Confidence	Evidence
CDMOS	CDMOS	90%	we outsource our manufacturing of clinical trial materials to CDMOs
CROS	CROS	90%	We primarily outsource our clinical trial administration to CROs
INVESTIGATIVE-SITES	INVESTIGATIVE-SITES	80%	costs incurred under clinical trial agreements with CROs and investigative sites
LABORATORY-SUPPLIES	LABORATORY-SUPPLIES	70%	costs for laboratory supplies

aTyr Pharma, Inc. Customers

Ticker	Name	Confidence	Evidence
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from ATYR graph: duce preclinical, clinical and commercial supplies of our product candidates. Other than some internal capacity to su…
MYGN	Myriad Genetics, Inc.	72%	duce preclinical, clinical and commercial supplies of our product candidates. Other than some internal capacity to support preclinical activities, we do not have, nor do we plan to acquire, the infra…

aTyr Pharma, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ATYR-DEBT-7965	Warrants outstanding: 263000	90%	xbrl warrant detail from xbrl 2017-12-31.
ATYR-DEBT	Debt stack $5.8M	90%	Market cache reports total debt of $5.8M.
ATYR-DEBT-7966	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2015-12-31.

aTyr Pharma, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for aTyr Pharma, Inc..

aTyr Pharma, Inc. Ownership

Holder	Name	Confidence	Evidence
ATYR-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 113 tracked holders.

aTyr Pharma, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
JANX	Janux Therapeutics, Inc.	100.00	2
TEM	Tempus AI, Inc.	100.00	2
KDK	Kodiak AI, Inc.	100.00	2
DNLI	Denali Therapeutics Inc.	100.00	2
IRD	Opus Genetics, Inc.	100.00	2
BNTC	Benitec Biopharma Inc.	100.00	2
BNBX	BNB Plus Corp.	100.00	2
ALLO	Allogene Therapeutics, Inc.	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
CABA	Cabaletta Bio, Inc.	100.00	2
SDGR	Schrödinger, Inc.	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
ELVN	Enliven Therapeutics, Inc.	100.00	2
BIAF	bioAffinity Technologies, Inc.	100.00	2
CALC	CalciMedica, Inc.	100.00	2
IMNM	Immunome, Inc.	100.00	2
PSNL	Personalis, Inc.	100.00	2
HOWL	Werewolf Therapeutics, Inc.	100.00	2
GH	Guardant Health, Inc.	100.00	2
MYGN	Myriad Genetics, Inc.	100.00	1	['customer']

aTyr Pharma, Inc. Supply Chain